Skip to main content

About Study Course

Credit points / ECTS:5 / 7.5
Course supervisor:Valērija Groma
Study type:Full time
Course level:Master's
Target audience:Life Science
Language:Latvian
Branch of science:Clinical Medicine; Histology and Cytology

Objective

Students should acquire knowledge of the cell structure and its functions, be familiar with modern cell research techniques and equipment; they should understand structural and functional changes of the cell, and understand the role of these changes in the pathogenesis of human diseases.

Prerequisites

Biology, chemistry, histology, anatomy and physiology in correspondence with the bachelor programme.

Learning outcomes

Knowledge

After successful completion of the study course, the student will be able to:
• Describe the cell structure and the processes within the cell;
• Describe the signalling molecules and explain their role in the regulation of cell processes;
• Classify and describe cytoplasmic organelles and inclusions, and explain their role in human pathology;
• Identify and describe the methods used for study of cells, their nature and application in the field of biomedicine;
• Explain impairment of cell structure and function and how these can contribute to development of disease.

Skills

After completion of the study course, the students will be able to evaluate cells when using a light microscope;
the student will be able to detect main ultrastructural features of changes in cells; will be able to improve their knowledge of cell research methods and will be able to apply these methods in medicine.

Competence

Students will be able to recognize cell and cell microstructure morphology in slides and pictures of the science of cell biology. They will be able to distinguish between healthy and pathological cells generally and they will analyse variations at different cell adaptation processes.
They will be able to evaluate the quality and methods of specimens and the way they might be used in clinic.

Study course planning

Course planning not avalible right now.